CorFlow Therapeutics AG
PrivateLast Round
Series B
Sep 9, 2024
Total Funding Raised
$58.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CorFlow Therapeutics AG is a medical technology company that develops diagnostic and therapeutic devices for the treatment of microvascular obstruction in heart attack patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CorFlow Therapeutics AG Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
CorFlow Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 9, 2024 | ||||
| Seed | Sep 12, 2018 |
Key People
Founding team and executive leadership
CorFlow Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOFA Healthcare | Series B |
| 415 Capital | Series B |
| Unorthodox Ventures | Series B |
| Panakès Partners | Series B |
| Wellington Partners | Series B |
| M&L Healthcare | Series B |
| M&L Healthcare Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Second generation CoFI system now in clinical trials.
- May 6, 2025
Rick Geoffrion stepped down as Chairman, replaced by Chris O'Connell.
CorFlow Therapeutics AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CorFlow Therapeutics AG's valuation, stock price, and market status.